671 related articles for article (PubMed ID: 33983621)
21. Time-to-event estimands and loss to follow-up in oncology in light of the estimands guidance.
Siegel JM; Weber HJ; Englert S; Liu F; Casey M;
Pharm Stat; 2024 Mar; ():. PubMed ID: 38553421
[TBL] [Abstract][Full Text] [Related]
22. Defining estimands in clinical trials: A unified procedure.
Han S; Zhou XH
Stat Med; 2023 May; 42(12):1869-1887. PubMed ID: 36883638
[TBL] [Abstract][Full Text] [Related]
23. Single-world intervention graphs for defining, identifying, and communicating estimands in clinical trials.
Ocampo A; Bather JR
Stat Med; 2023 Sep; 42(21):3892-3902. PubMed ID: 37340887
[TBL] [Abstract][Full Text] [Related]
24. A note on the draft International Council for Harmonisation guidance on estimands and sensitivity analysis.
Mehrotra DV
Clin Trials; 2019 Aug; 16(4):339-344. PubMed ID: 30977390
[TBL] [Abstract][Full Text] [Related]
25. Estimating the treatment effect for adherers using multiple imputation.
Luo J; Ruberg SJ; Qu Y
Pharm Stat; 2022 May; 21(3):525-534. PubMed ID: 34927339
[TBL] [Abstract][Full Text] [Related]
26. Estimands: discussion points from the PSI estimands and sensitivity expert group.
Phillips A; Abellan-Andres J; Soren A; Bretz F; Fletcher C; France L; Garrett A; Harris R; Kjaer M; Keene O; Morgan D; O'Kelly M; Roger J
Pharm Stat; 2017 Jan; 16(1):6-11. PubMed ID: 26997517
[TBL] [Abstract][Full Text] [Related]
27. Application of hypothetical strategies in acute pain.
Zhong J; Petullo D
Pharm Stat; 2024; 23(3):399-407. PubMed ID: 38211946
[TBL] [Abstract][Full Text] [Related]
28. Estimands and Complex Innovative Designs.
Collignon O; Schiel A; Burman CF; Rufibach K; Posch M; Bretz F
Clin Pharmacol Ther; 2022 Dec; 112(6):1183-1190. PubMed ID: 35253205
[TBL] [Abstract][Full Text] [Related]
29. Estimation of causal effects in clinical endpoint bioequivalence studies in the presence of intercurrent events: noncompliance and missing data.
Lou Y; Jones MP; Sun W
J Biopharm Stat; 2019; 29(1):151-173. PubMed ID: 29995564
[TBL] [Abstract][Full Text] [Related]
30. The detailed clinical objectives approach to designing clinical trials and choosing estimands.
Bell J; Hamilton A; Sailer O; Voss F
Pharm Stat; 2021 Nov; 20(6):1112-1124. PubMed ID: 34013553
[TBL] [Abstract][Full Text] [Related]
31. Estimands in hematologic oncology trials.
Sun S; Weber HJ; Butler E; Rufibach K; Roychoudhury S
Pharm Stat; 2021 Jul; 20(4):793-805. PubMed ID: 33686762
[TBL] [Abstract][Full Text] [Related]
32. Understanding estimands.
Gogtay NJ; Ranganathan P; Aggarwal R
Perspect Clin Res; 2021; 12(2):106-112. PubMed ID: 34012908
[TBL] [Abstract][Full Text] [Related]
33. Handling Missing Data and Drop Out in Hospice/Palliative Care Trials Through the Estimand Framework.
Grobler AC; Lee KJ; Wong A; Currow DC; Braat S
J Pain Symptom Manage; 2022 Apr; 63(4):e431-e439. PubMed ID: 34954068
[TBL] [Abstract][Full Text] [Related]
34. Estimands in observational studies: Some considerations beyond ICH E9 (R1).
Li H; Wang C; Chen WC; Lu N; Song C; Tiwari R; Xu Y; Yue LQ
Pharm Stat; 2022 Sep; 21(5):835-844. PubMed ID: 35128808
[TBL] [Abstract][Full Text] [Related]
35. Principles and recommendations for incorporating estimands into clinical study protocol templates.
Lynggaard H; Bell J; Lösch C; Besseghir A; Rantell K; Schoder V; Lanius V
Trials; 2022 Aug; 23(1):685. PubMed ID: 35986349
[TBL] [Abstract][Full Text] [Related]
36. Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial.
Weir IR; Dufault SM; Phillips PPJ
Trials; 2024 Mar; 25(1):180. PubMed ID: 38468320
[TBL] [Abstract][Full Text] [Related]
37. Estimands in published protocols of randomised trials: urgent improvement needed.
Kahan BC; Morris TP; White IR; Carpenter J; Cro S
Trials; 2021 Oct; 22(1):686. PubMed ID: 34627347
[TBL] [Abstract][Full Text] [Related]
38. Sample Size Calculation When Planning Clinical Trials with Intercurrent Events.
Fang Y; Jin M
Ther Innov Regul Sci; 2021 Jul; 55(4):779-785. PubMed ID: 33821445
[TBL] [Abstract][Full Text] [Related]
39. Statistical methods for handling missing data to align with treatment policy strategy.
Wang Y; Tu W; Kim Y; Sinks S; He J; Cambon A; Crackel R; Hamilton K; Kettermann A; Clark J
Pharm Stat; 2023; 22(4):650-670. PubMed ID: 36970810
[TBL] [Abstract][Full Text] [Related]
40. Application of the Estimand Framework to Anesthesia Trials.
De Silva AP; Leslie K; Braat S; Grobler AC
Anesthesiology; 2024 Jul; 141(1):13-23. PubMed ID: 38743905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
